← 治験一覧に戻る
原発性乳がん患者における卵巣機能に対するゴセレリン酢酸塩の研究
基本情報
- NCT ID
- NCT00429403
- ステータス
- 中止
- 試験のフェーズ
- 第3相
- 試験タイプ
- 介入
- 目標被験者数
- 1
- 治験依頼者名
- M.D. Anderson Cancer Center
概要
Primary Objective: * To determine the effectiveness of goserelin acetate (Zoladex) in preserving ovarian function in premenopausal women undergoing neoadjuvant and/or adjuvant chemotherapy for primary invasive breast cancer by documenting persistence or resumption of regular menses. Secondary Objectives: * To determine the incidence of pregnancy and the effect for participants' quality of life (QOL) after chemotherapy. * To determine the overall survival and disease-free survival times of study participants.
対象疾患
Breast Cancer
介入
Goserelin(DRUG)
依頼者(Sponsor)
M.d. Anderson Cancer Center(OTHER)
実施施設 (1)
聖路加国際病院
Tokyo, Japan